The CTC1 gene helps protect telomeres, the caps at the ends of chromosomes, and supports accurate DNA copying. This gene plays an important role in keeping blood, brain, eye, and gut cells working normally. If the gene does not work well, people may develop inherited conditions linked to poor growth, low blood counts from bone marrow failure, bleeding in the digestive tract, eye disease, and changes in the brain. Pathogenic variants in the CTC1 gene are a known cause of Coats plus syndrome and some related telomere conditions.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes give the directions for producing proteins, the parts of cells that do much of the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. You can find more detailed information on this topic in the LearnHub.
Overview
CTC1Gene function
What if the gene works
The CTC1 gene helps protect telomeres, the caps at chromosome ends. It also supports normal DNA copying, which helps cells divide in a controlled way and maintain stable genetic material.
Risk
What if the gene does not work
Variants in the CTC1 gene can disrupt telomere maintenance. More severe variants often cause poor growth, eye and brain blood vessel changes, and bone marrow failure, while milder variants may lead to later onset or fewer features.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic variants in the CTC1 gene. Care is guided by the person’s complications rather than the CTC1 result itself, while the CTC1 gene is being studied in telomere biology and as a possible cancer biomarker.
Conditions associated with CTC1
Gene function
What if the gene works
Each time a cell divides, it has to copy the full length of its DNA and carefully manage the tips of chromosomes. The CTC1 gene helps with both jobs, especially at telomeres, the protective caps at chromosome ends. Understanding what the CTC1 gene does helps explain how cells keep these chromosome ends stable during routine growth and repair.
The CTC1 gene helps cells manage telomeres during DNA copying. It guides work at chromosome ends so these protective caps are handled in a controlled, orderly way.
One of its main roles is to help complete the matching DNA strand at chromosome ends after the first strand has been lengthened. This helps leave telomeres with the right shape for the next round of cell division.
The protein from the CTC1 gene also helps DNA copying continue through hard to copy stretches. It works with partner proteins and the cell's copy system so routine growth can stay steady.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including traits such as appearance, metabolism, and the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply fall within the usual range of natural genetic variation. In some situations, however, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CTC1 gene can weaken the CTC1 protein, reduce its stability, or disrupt how it joins partner proteins to protect and copy telomeres (the protective DNA caps at chromosome ends). In how CTC1 gene variants affect protein function, milder variants may leave some activity, while more severe variants can cause a much larger loss of function. This often leads to greater trouble maintaining chromosome ends, and in CTC1 related conditions it may be linked to earlier or more pronounced features.
How variants are linked to conditions
Pathogenic variants in the CTC1 gene cause cerebroretinal microangiopathy with calcifications and cysts, often described within the Coats plus syndrome spectrum. This CTC1 gene condition can affect vision, brain scans, bone health, digestion, and blood counts. Variants in the CTC1 gene have also been linked to some other inherited conditions marked by bone marrow failure, short stature, or features of dyskeratosis congenita.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CTC1-related conditions, risk is driven mainly by the gene changes a person is born with rather than by lifestyle or everyday exposures. There is not enough evidence to say that diet, exercise, or other routine habits lower the chance of developing a CTC1-related condition. Family history and whether one or two changed copies of CTC1 are present are the main factors that shape risk.
Inheritance of CTC1 variants
Variants in the CTC1 gene are inherited in an autosomal recessive pattern for the well-established CTC1-related conditions. This means a child usually inherits one altered copy from each parent, and parents who each carry one variant are typically unaffected carriers. When both parents carry a CTC1 gene variant, each pregnancy has a 25% chance of resulting in an affected child, a 50% chance of a carrier child, and a 25% chance of a child with two typical copies. In practical terms, how CTC1 gene variants are inherited usually comes down to whether both parents carry the same condition-linked variant.
What does my CTC1 result mean for my family?
For CTC1, family implications are usually discussed in the context of a recessive condition. This often means parents carry the variant without having the condition, while brothers and sisters may also be affected or may be carriers. Other relatives on both sides of the family could be carriers as well, so the result may be relevant beyond just one person.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CTC1 gene, doctors use genetic testing for CTC1 variants on a blood or saliva sample. A lab reads the DNA and checks for changes in the CTC1 gene, then reports whether a variant is known to cause disease, appears harmless, or is still unclear.
When should I consider getting a genetic test?
Consider genetic testing for the CTC1 gene if you or your child has a rare combination of poor growth, eye disease, low blood counts, brain scans showing calcium buildup or cysts, or unexplained bleeding, especially if similar problems run in the family. It can also help explain some inherited bone marrow failure conditions.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to its effects. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and are one part of the bigger picture, along with age, liver and kidney function, other medicines, and overall health.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It studies links between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can help support more informed, individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CTC1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or what side effects they may cause. Questions about symptoms, a diagnosis linked to this gene, or any medication concerns are best discussed with your doctor.